col : main author | no. of patients | duration of follow-up years | linearized rate of infection | actuarial freedom from infective endocarditis row 1 : pavie | 675 | 5 | nan | 98.2% for all patients, 97.8% for a row 2 : duncan (a) | 2720 | 6 | nan | 97.3% for all patients, 97.4% for a row 3 : ionescu (b) | 1171 | 10 | nan | 93.7% for all patients, 94.7% for a row 4 : zhu | 520 | 10 | nan | 98% for all patients row 5 : revuelta | 239 | 8 | 0.67% per patient year | nan row 6 : garcia-bengochea | 248 | 8 | 0.78% per patient year | nan row 7 : holden (c) | 290 | 6 | 1.1% per patient year | nan row 8 : bachet (d) | 224 | 6 | 1.6% per patient year | nan
who are the main authors of pericardial heart valves? of these authors, which have information listed under actuarial freedom from ineffective endocarditis?
pavie, duncan (a), ionescu (b), zhu
Main author No. of patients Duration of follow-up years Linearized rate of infection Actuarial freedom from infective endocarditis
of these authors, which have information listed under actuarial freedom from ineffective endocarditis?
Pavie 675 5 nan 98.2% for all patients, 97.8% for a
Duncan (A) 2720 6 nan 97.3% for all patients, 97.4% for a
Ionescu (B) 1171 10 nan 93.7% for all patients, 94.7% for a
Zhu 520 10 nan 98% for all patients
Revuelta 239 8 0.67% per patient year nan
Garcia-Bengochea 248 8 0.78% per patient year nan
Holden (C) 290 6 1.1% per patient year nan
Bachet (D) 224 6 1.6% per patient year nan
Pavie Duncan (A) Ionescu (B) Zhu
of these authors, which have information listed under actuarial freedom from ineffective endocarditis? || who are the main authors of pericardial heart valves?